Combination therapy with type i and type ii anti-cd20...

Details Combination therapy with type i and type ii anti-cd20... Combination therapy with type i and type ii anti-cd20...

C - Chemistry, Metallurgy

07

K

C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2697482

The present application is directed to the combination therapy of a type I and a type II anti-CD20 antibody for the treatment of cancer, especially of CD20 expressing cancer.

La présente invention concerne la polythérapie d'un anticorps anti-CD20 de type I et d'un anticorps anti-CD20 de type II pour le traitement du cancer, notamment du cancer exprimant CD20.

Affiliated with

Also associated with

Rating

Combination therapy with type i and type ii anti-cd20... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy with type i and type ii anti-cd20..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with type i and type ii anti-cd20... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1558825